Repertoire diversity and dynamics of peripheral Th17 after allogeneic haematopoietic stem cell transplantation
- 15 October 2026
- journal article
- Published by Wiley in British Journal of Haematology
Abstract
Summary: Th17, a subset of helper T cells that produce interleukin‐17 (IL‐17), is thought to play a pivotal role in the pathogenesis of chronic graft‐versus‐host disease (GVHD). However, the kinetics of Th17 following allogeneic haematopoietic stem cell transplantation (allo‐HSCT) have not been elucidated. In this study, we evaluated the temporal dynamics and diversity of peripherally circulating Th17 after allo‐HSCT. The study included 86 patients who survived without disease relapse for 1 year or more, and for whom peripheral blood samples 3 months after allo‐HSCT were available. Th17 was detected and sorted by flow cytometry, and T‐cell receptor (TCR) repertoire was analysed by a next‐generation sequencing (NGS) method. Patients with chronic GVHD showed a higher TCR repertoire diversity, while those with severe chronic GVHD showed a lower TCR diversity and Th17/Cluster of Differentiation (CD) 4 ratio. The amino acid sequence in complementarity determining region 3 of Th17‐TCR was not apparently different between patients with and without chronic GVHD. Additionally, a higher Th17/CD4 ratio at 3 months was related to a lower incidence of subsequent chronic GVHD. The current study explored the kinetics of peripherally circulating Th17 after allo‐HSCT, which might be associated with the development of chronic GVHD.Keywords
Funding Information
- Jichi Medical University
- Japan Society for the Promotion of Science (JP21K07070)
- Terumo Foundation for Life Sciences and Arts
- Japan Agency for Medical Research and Development (JP24ek0510046)
This publication has 59 references indexed in Scilit:
- Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid ArthritisArthritis & Rheumatology, 2023
- The role of TH17 cells in multiple sclerosis: Therapeutic implicationsAutoimmunity Reviews, 2020
- T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2020
- Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of LifeTransplantation and Cellular Therapy, 2019
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2015
- Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchTransplantation and Cellular Therapy, 2015
- Targeting the IL17 Pathway for the Prevention of Graft-Versus-Host DiseaseTransplantation and Cellular Therapy, 2014
- Alemtuzumab for the prevention and treatment of graft-versus-host diseaseInternational Journal of Hematology, 2011
- TLR2‐activated human langerhans cells promote Th17 polarization via IL‐1β, TGF‐β and IL‐23European Journal of Immunology, 2009
- Glucocorticoids in T cell apoptosis and functionCellular and Molecular Life Sciences, 2005